Recent developments with Travere Therapeutics Inc (TVTX) have led to the company’s beta value being reach 0.69 cents.
On Tuesday, Travere Therapeutics Inc (NASDAQ: TVTX) was -2.06% drop from the session before settling in for the closing price of $17.50. A 52-week range